MARKET

PGEN

PGEN

Precigen Inc
NASDAQ
1.400
+0.020
+1.45%
Closed 19:43 04/23 EDT
OPEN
1.400
PREV CLOSE
1.380
HIGH
1.450
LOW
1.390
VOLUME
507.02K
TURNOVER
0
52 WEEK HIGH
1.880
52 WEEK LOW
0.8354
MARKET CAP
348.49M
P/E (TTM)
-3.5696
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at PGEN last week (0415-0419)?
Weekly Report · 2d ago
Weekly Report: what happened at PGEN last week (0408-0412)?
Weekly Report · 04/15 09:23
Weekly Report: what happened at PGEN last week (0401-0405)?
Weekly Report · 04/08 09:25
AquaBounty Technologies Inc reports results for the quarter ended in December - Earnings Summary
AquaBounty Technologies Inc reports results for the quarter ended in December. The company reported a quarterly adjusted loss of $2.19 per share. Revenue rose 22.8% to $554.00 thousand from the same quarter last year. Wall Street expected the company to report a profit of $1.53 per share in the quarter.
Reuters · 04/02 14:21
Weekly Report: what happened at PGEN last week (0325-0329)?
Weekly Report · 04/01 09:24
Analysts Offer Insights on Healthcare Companies: Precigen (PGEN), Cronos Group (CRON) and Marinus (MRNS)
TipRanks · 03/26 12:10
Weekly Report: what happened at PGEN last week (0318-0322)?
Weekly Report · 03/25 09:25
Precigen Cut to Underweight From Neutral by JP Morgan
Dow Jones · 03/22 16:22
More
About PGEN
Precigen, Inc. is a dedicated discovery and clinical-stage biopharmaceutical company advancing gene and cell therapies. The Company’s proprietary technology platforms develops product candidates designed to target urgent and intractable diseases in its core therapeutic areas of immuno-oncology, autoimmune disorders and infectious diseases. It has developed a pipeline of therapies across multiple indications. The Company operates through two segments: Biopharmaceuticals and Exemplar. Biopharmaceuticals segment is primarily comprised of the Company's legal entities of Precigen and ActoBio, as well as royalty interests in therapeutics and therapeutic platforms from companies not controlled by the Company. Exemplar segment is composed of Exemplar Genetics LLC, doing business as Precigen Exemplar (Exemplar), its wholly owned subsidiary focused on developing research models and services for healthcare research applications.

Webull offers Precigen Inc stock information, including NASDAQ: PGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PGEN stock methods without spending real money on the virtual paper trading platform.